What is Dermata Therapeutics Inc (DRMA) stock price today?

Dermata Therapeutics Inc (DRMA) currently trades at $1.37 per share. The stock has a market capitalization of $4.99M and a P/E ratio of —x.

Is DRMA stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Dermata Therapeutics Inc has a Smart Value Score of 26/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is the DRMA stock price target for 2026?

WallStSmart's 12-month price target for Dermata Therapeutics Inc is $1.37.

DRMA

Dermata Therapeutics Inc

NASDAQ: DRMA · HEALTHCARE · BIOTECHNOLOGY

$1.37

+8.73% today

Updated 2026-04-30

Market cap

$4.99M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-8.16

Dividend yield

—

52W range

$1 – $10

Volume

1.8M

Market cap

$4.99M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-8.16

Dividend yield

—

52W range

$1 – $10

Volume

1.8M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

5.0

Quality

C+

3.0

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$4.00

+191.97%

12-Month target

$1.37

+0.00%

Intrinsic (DCF)

—

Margin of safety

—

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Thin margins at 0.00%

- Negative free cash flow $-1.33M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-9.61M	$-7.79M	$-12.29M	$-7.56M	$-1.86M
EPS	—	—	—	—	$-8.16
Free cash flow	$-8.83M	$-6.41M	$-11.16M	$-7.76B	$-1.33M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
DRMA	$4.99M	26	4.3	3.0	5.0	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Dermata Therapeutics Inc trades at $1.37. Our Smart Value Score of 26/100 indicates the stock is weak.

Frequently asked questions

What is Dermata Therapeutics Inc's stock price?

Dermata Therapeutics Inc (DRMA) trades at $1.37.

Is Dermata Therapeutics Inc overvalued?

Smart Value Score 26/100 (Grade F, Strong Sell).

What is the price target of Dermata Therapeutics Inc (DRMA)?

The analyst target price is $4.00, representing +192.0% upside from the current price of $1.37.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-194.20%

Beta0.50

50D MA$1.29

200D MA$3.42

Shares out0.00B

Float0.00B

Short ratio—

Avg volume1.8M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

DRMA vs LLY →DRMA vs JNJ →DRMA vs ABBV →Stock screener →